Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroprotection and Neuroenhancement in a Model of Optic Nerve Neurodegeneration (Non Arteritic Ischemic Optic Neuropathy): Study of Morpho-functional Changes Related to Treatment With Citicoline Oral Solution

NCT03758118 is registered in ClinicalTrials.gov with Fondazione G.B. Bietti, IRCCS as lead sponsor.

NCT NCT03758118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03758118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroprotection and Neuroenhancement in a Model of Optic Nerve Neurodegeneration (Non Arteritic Ischemic Optic Neuropathy): Study of Morpho-functional Changes Related to Treatment With Citicoline Oral Solution
Lead sponsor
Fondazione G.B. Bietti, IRCCS
Phase
Not applicable
Overall status
Completed
Start date
February 20, 2017
Completion date
April 25, 2018
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-arteritic ischemic optic neuropathy